Literature DB >> 6394401

Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111.

J Stuart, S Norrell, J P Harrington.   

Abstract

Previous studies have suggested that human lactoferrin has a bacteriostatic effect on Escherichia coli 0111 growth. Determination of the time required for cultures to reach one-half maximal cell density (t1/2) indicates that within the concentration range of lactoferrin used in this study, its effect in vitro on the growth of E. coli 0111 is kinetic rather than bacteriostatic. Compared to a control, added apo-lactoferrin (250-1000 micrograms/ml) produced only a delay effect as seen by an increase in the t1/2 indicating these concentrations are probably within the subinhibitory concentration range. The kinetic delay effect of apo-lactoferrin is also consistently increased in the presence of Zn2+ and Cu2+ cations. Cu2+, Zn2+ and NTA (nitrilotriacetate) did not affect the growth rate of this organism in the absence of lactoferrin compared to the control. These studies indicate that the mechanism by which lactoferrin alters the bacterial growth of E. coli 0111 is more complex than simple iron deprivation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6394401     DOI: 10.1016/0020-711x(84)90085-5

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  12 in total

1.  Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.

Authors:  D Caccavo; A Afeltra; S Pece; G Giuliani; M Freudenberg; C Galanos; E Jirillo
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Microparticle-enhanced nephelometric immunoassay of lactoferrin in human milk.

Authors:  M L Cuillière; P Montagne; C Molé; M C Béné; G Faure
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin.

Authors:  R T Ellison; T J Giehl; F M LaForce
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

4.  Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide.

Authors:  M Yamaguchi; M Matsuura; K Kobayashi; H Sasaki; T Yajima; T Kuwata
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

5.  Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium.

Authors:  S S Naidu; U Svensson; A R Kishore; A S Naidu
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

6.  Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.

Authors:  Henry F Gomez; Theresa J Ochoa; Irene Herrera-Insua; Lily G Carlin; Thomas G Cleary
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Expression of human lactoferrin in milk of transgenic mice.

Authors:  G J Platenburg; E P Kootwijk; P M Kooiman; S L Woloshuk; J H Nuijens; P J Krimpenfort; F R Pieper; H A de Boer; R Strijker
Journal:  Transgenic Res       Date:  1994-03       Impact factor: 2.788

8.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Antibacterial prophylaxis with lactoferrin in neutropenic patients.

Authors:  U Trümpler; P W Straub; A Rosenmund
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

10.  Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea.

Authors:  T Fujihara; K Hayashi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.